Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa - Wikidata - awgldk - TriplyDB

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

http://www.wikidata.org/entity/Q24548845

about

Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.Systematic review and meta-analysis of Saccharomyces boulardii in adult patients Potential uses of probiotics in clinical practice The Microbiota and Health Promoting Characteristics of the Fermented Beverage Kefir Alternatives to Antibiotics to Prevent Necrotic Enteritis in Broiler Chickens: A Microbiologist's Perspective Probiotic use in horses - what is the evidence for their clinical efficacy?Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system Gut bacteria in health and disease Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions Probiotics-host communication: Modulation of signaling pathways in the intestine.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science A Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with Diarrhea.Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.Pathogenesis and treatment of Clostridium difficile infection Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases Clostridium difficile infection: new insights into management.Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.Clinical update for the diagnosis and treatment of Clostridium difficile infection.Treatment of Recurrent Clostridium difficile Diarrhea Beneficial effects of probiotic and food borne yeasts on human health Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications The role of probiotics and prebiotics in inducing gut immunity.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.

P2860

Q21198789-6A9C6153-2A22-450C-9AD1-67F2E5ACD459 Q24529831-74EA2C73-E0C7-46D0-8030-02889F104CC2 Q24545538-A29E0F91-22EA-4E00-92E1-41F09F36D1A7 Q24621081-0F893D6E-F001-46E7-86BB-5694052D60E5 Q24681377-8E7C1708-1DFC-49F9-AA1F-7AE1D5D1CBB7 Q26747430-A7734147-5EE1-4EAE-B997-05C9CE965E7E Q26773141-738CA51E-5205-4186-BF78-2F884742FC09 Q27021831-0D7896F8-4C04-48AE-9F13-67D3C59FDB21 Q27027602-C43E1B67-81B5-4FDE-AF64-DB67C1799FA0 Q28066899-A872AEF6-55E7-4F1F-9805-D23F126A8AB4 Q28238138-870CA124-12B3-412D-9B03-A383F48B3D2A Q28475053-A50876A6-9910-4661-9555-16E22B0C29B5 Q28741411-E45BD91E-027C-4006-B6FF-606433F976D2 Q28741795-2BF64B29-1DC8-41BD-BC5F-917D60C5B43A Q33890323-CE40DB25-03E6-45B0-81D4-FB46B3D6B699 Q33958897-680DD7B1-FEA6-4443-9115-0595C3E42947 Q34018028-2E8215BC-2DA0-48D0-8F64-7550292E5549 Q34162963-C2FC3CB5-D7FE-4147-B662-3684554EE156 Q34378800-E79B9902-85C4-4F65-AAD1-35A688729CDC Q34554028-3CF581A5-EFFB-4A42-A91B-2889D4FA4F42 Q34723329-FF242BD9-2D9E-4567-AF96-9057ED0F6AE6 Q35540167-4482CBF7-43A0-4A4E-A683-65639F592E72 Q35621330-DDFA07ED-84BE-4E92-9E37-CF4610E03453 Q36152528-7958E43D-BC46-4698-91ED-C45FCF3A06F3 Q36449677-218070F8-1130-47E9-AB9E-BE9CFA4579E2 Q36523440-D76BADFA-06E9-47FE-8D3B-C7FA89A78FC1 Q37009989-61F530BA-5DF3-4D15-8E88-FAC3CE0F485B Q37586528-CBA15527-E425-4F9F-B85C-B8E840EC70F6 Q37633859-DF2EA559-946E-4186-858A-DB041741C21B Q37678919-B49FBE58-AFB5-4311-9717-9AAD3A6DA34E Q37976693-0D97F02D-D31F-4097-AED2-EBD8A9DBB21D Q37994188-411725B0-F984-4D47-AB72-533ED99B1C09 Q38069827-4C0BAA66-137D-421B-95D3-182C51EEC7D7 Q38174603-4B111B5F-DB58-4749-BFD7-489C21E8F1A2 Q38794312-7BD709F7-B9C0-4358-AF28-88E514A7D3C8 Q38822566-855EAF06-5B9F-47AA-8687-43306BC0C9CE Q39519683-F5AE713F-F5A5-4183-A6FD-94C7A987E606 Q40099400-34FF053F-0C8D-4F7D-B013-DFF3FABEDEC9 Q40579622-CBDE02C6-2005-4E9D-A756-8BF6C6587D8B Q41824565-BCB4732E-151F-4C55-9EDF-AD22323D32F5

P2860

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

http://www.wikidata.org/entity/Q24548845

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@ast

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@en

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@nl

type

label

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@ast

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@en

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@nl

prefLabel

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@ast

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@en

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@nl

P1433

Q24548845-0E89A757-69B8-41B4-A4FC-5EC500344190

P1476

Q24548845-45AA6A92-F640-411C-9B13-7BAC97FE6994

P2093

Q24548845-275D4326-E48B-4B4B-B1B9-E4274BA37E8D

Q24548845-4A75B1AB-B822-47DA-823F-7D899114E45A

Q24548845-764917A7-E2D5-4CCF-81DF-5C33741B011C

Q24548845-B5DC57D2-2D28-42E8-8E8B-6EC80A5CEF8B

Q24548845-B798AFA0-3D3F-49C8-A530-6677D375442C

P2860

Q24548845-1863EE18-7608-4DDF-9CD1-CA631B337CAB

Q24548845-1D318966-8CC8-411D-9C85-20A3F44420EB

Q24548845-2079BCAB-4262-4245-8D8F-93F86D7F3BF4

Q24548845-26E8A701-F92C-4A31-B880-803D52E61E93

Q24548845-55AA133E-7F09-402A-A8B8-D6A0F617E3ED

Q24548845-5B2069B3-FF10-4E23-96AE-D7746A48F7D9

Q24548845-6234603F-16C1-403B-8570-FCC7AE35DE44

Q24548845-6CE94DCA-55D2-4985-918F-227810762A6E

Q24548845-7A441054-DCF6-4C16-89D3-7824E2D3A7D1

Q24548845-86F8E495-7D8B-4CB0-A575-9B00AF367465

P304

Q24548845-F2C23790-C0CF-43FF-A238-658B9647C400

P31

Q24548845-82D3E051-7534-4B4D-B870-AE235EF66829

P3181

Q24548845-6951BCD0-3808-49E0-9059-6A44C77DC763

P356

Q24548845-48C129C9-F97B-469F-B4C5-11D9DCABF54F

P407

Q24548845-6321F52D-AE9B-44D9-8708-C50C49422492

P433

Q24548845-A90213BE-0AAB-475F-8E8F-A044B9594314

P478

Q24548845-5CF1E38B-0618-4E6C-B1CE-1E1E866706C0

P577

Q24548845-F7C00DE7-EBCB-4D41-BD3F-E6BF8200702D

P698

Q24548845-0B832EB5-01CB-4AB6-A8CE-CEEE3C950DAE

P921

Q24548845-D3B833E3-4BB6-4796-A12E-0C930ADDBA5C

P932

Q24548845-A7E5B4EA-80A4-4AB7-A624-5B42A9EF088F

P3181

P356

S0016-5085(98)83862-6

P1433

Infection and Immunity

P1476

Saccharomyces boulardii protea ...... and B in human colonic mucosa

@en

P2093

C Pothoulakis

http://www.w3.org/2001/XMLSchema#string

I Castagliuolo

http://www.w3.org/2001/XMLSchema#string

J T LaMont

http://www.w3.org/2001/XMLSchema#string

L Valenick

http://www.w3.org/2001/XMLSchema#string

M F Riegler

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers

Purification and characterization of toxins A and B of Clostridium difficile

Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit

Clostridium difficile: its disease and toxins

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii

Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro

Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein

P304

302-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1855503

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0016-5085(98)83862-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9864230

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

96311

http://www.w3.org/2001/XMLSchema#string